Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Current Treatment Options in Neurology
Metadata
Title
Allergy: A risk factor for suicide?
Authors
Teodor T. Postolache
Hirsh Komarow
Leonardo H. Tonelli
Publication date
01-09-2008
Publisher
Current Science Inc.
Published in
Current Treatment Options in Neurology / Issue 5/2008
Print ISSN: 1092-8480
Electronic ISSN: 1534-3138
DOI
https://doi.org/10.1007/s11940-008-0039-4

Other articles of this Issue 5/2008

Current Treatment Options in Neurology 5/2008 Go to the issue

OriginalPaper

Sleep dysfunction in heart failure

OriginalPaper

Nonpharmacologic treatment of insomnia

OriginalPaper

Transcranial direct current stimulation for major depression: A general system for quantifying transcranial electrotherapy dosage

OriginalPaper

Sleep in children with autism spectrum disorders

OriginalPaper

Delirium: Underrecognized and undertreated

OriginalPaper

Treatment of complex sleep apnea syndrome